Who
Rimma Driscoll
Executive Vice President
Company insider
Files Form 4 as: Executive Vice President, Zoetis; Director, DexCom.
In numbers
- Trades disclosed
- 82
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 13 Jan 2023
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $7,269277.772 at $26.17 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $6,231237.636 at $26.22 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $6,231237.64 at $26.22 | filing |
| 28 May 2026filed 1 Jun 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,605 at $0.00 | filing |
| 28 May 2026filed 1 Jun 2026 | DXCM DexComMedical Devices | SEC FORM 4 Code A | —5,605 at $0.00 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,03826.198 at $39.64 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $1,03926.2 at $39.64 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $25K641.744 at $38.20 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $25K641.74 at $38.20 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —454 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $23K179 at $127.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —454.634 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —454.63 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —454 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $23K179 at $127.28 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,323 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,191 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —2,323 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —9,191 at $0.00 | filing |
| 8 Feb 2026filed 10 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —192 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.